Truist Financial Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $1,281

robot
Abstract generation in progress

Truist Financial has reaffirmed its Buy rating on Eli Lilly and Co (LLY.US) and has set a target price of $1,281 for the company’s stock. This indicates a positive outlook from the firm regarding Eli Lilly’s future performance.

LLY-0.55%
US1.18%
RATING9.25%
ON-8.57%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned